Biotech Strategy Blog

Commentary on Science, Innovation & New Products

Posts tagged ‘Clinical Research’

Do you have a policy for the handling of incidental findings in clinical trial medical images?

By on February 1, 2011

I was supposed to be at the Innovation in Healthcare Symposium today at MIT in Cambridge, MA, but the winter ice storm that’s set to hit the North East has forced me to change my plans and return early from Boston to New Jersey. I am hoping to outrun the storm this morning (unlikely I know).

Hopefully, the presentations will be videoed and uploaded to You Tube or Webcast. Having traveled to Boston specially, I’m disappointed not to be able to write about the Symposium as planned.

This is a preview of Do you have a policy for the handling of incidental findings in clinical trial medical images?. Read the full post

Leave a comment

Antares Pharma has promising gel based contraceptive

By on October 26, 2010

Screen shot 2010 10 26 at 4.14.56 PM 300x139 Antares Pharma has promising gel based contraceptiveAs reported today by BBC News,  a NJ based specialist pharmaceutical company, Antares Pharma has developed a gel based contraceptive, Nesterone® that is as effective as taking a pill, acccording to phase 2 clinical trial data presented at the annual meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

According to researchers, the contraceptive delivered by the gel is as effective as that delivered by a traditional pill, but doesn’t show many of the adverse events and side effects such as weight gain & acne.  As always with promising phase 2 data, there is no guarantee that the phase 3 trial will show the same results, but this is definitely an innovative product to watch.

This is a preview of Antares Pharma has promising gel based contraceptive. Read the full post

Leave a comment

Welcome to the Biotech Strategy Blog

By on February 21, 2010

Welcome to the biotech strategy blog which provides commentary and insight on current news and emerging trends in biotechnology.

As a strategy and marketing consultant with a background in clinical development I am interested in how biotechnology companies grow, manage alliances, partner with CROs and bring new products to market. I hope that you will find posts on this blog to be informative and interesting.

Permanent link to this post (65 words, estimated 16 secs reading time)
Leave a comment